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April 10, 2012:1407–11Coincidentally, we recently reported a study that analyzed the
relationships between coronary stenoses and vessel structure as-
sessed by CTA, PET-derived MFR, and cardiovascular risk factors
(2). We showed that abnormal wall structure affects regional MFR
beyond the presence and severity of coronary stenoses. Specifically,
coronary calcium content was the main determinant of regional
MFR and a significant predictor of depressed global MFR.
Interestingly, when the Framingham risk score, an indicator of
overall cardiovascular risk, was considered; it remained the only
significant determinant of global MFR, beyond CTA variables.
Although the 2 investigations are similar with regard to baseline
characteristics of patients and differ only slightly in their method-
ology, they come to apparently different conclusions. In our view,
however, both studies point to the effects of diffuse coronary
atherosclerosis, in addition to those of focal significant stenoses, on
myocardial perfusion.
Accordingly, depressed regional MFR is closely linked to the
coronary atherosclerotic burden in the related vessel, described by
the “summed stenosis score” in the study by Naya et al. (1) and by
the coronary calcium content in ours (2). Moreover, global MFR
is consistently related to different indicators of cardiovascular risk,
the Duke CAD index in the study by Naya et al. (1), and the
Framingham risk score in ours (2).
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Reply
We appreciate the commentary by Drs. Liga and Neglia regarding
the relationship between coronary anatomic features and quan-
titative myocardial flow reserve (MFR) as assessed by cardiac
hybrid positron emission tomography/computed tomography.
We agree that both studies consistently demonstrate that the
total burden of atherosclerosis, quantified with coronary cal-
cium score (1) or by the total stenosis score, which integrates
the effects of serial plaques (2), contributes to downstream
MFR more than stenosis severity alone. However, we would not
characterize MFR as being “closely linked to atherosclerotic
burden.” Rather, both studies as well as other studies using
invasive angiography (3) have demonstrated that the correlation
etween epicardial stenosis severity and quantitative measures
f perfusion, although significant, is only modest in magnitude.
his is likely due to the fact that anatomic descriptors ofepicardial stenosis cannot capture the effects of diffuse athero-
sclerosis on vasodilator function of either the epicardial coro-
nary arteries or the microvasculature. Nonetheless, we believe
that both studies add valuable insights to the literature regard-
ing the determinants and role of MFR, which will have
increasing clinical application given its powerful prognostic
significance (4).
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Limitations of Noninvasive
Measurement of Fractional Flow
Reserve From Coronary
Computed Tomography
Angiography
We read with interest the paper by Koo et al. (1) regarding the
diagnostic accuracy of noninvasive measurement of fractional flow
reserve (FFR) from coronary computed tomography angiography
data (FFRCT). We do recognize the potential clinical and eco-
nomic relevance of the validation of a diagnostic tool able to
noninvasively determine the presence of ischemia-inducing coro-
nary lesions because it would dramatically reduce the number of
diagnostic angiograms and guide subsequent coronary revascular-
ization. However, we have some concerns regarding the interpre-
tation of the results of the study.
First, the major potential drawback of FFRCT relates to the fact
that FFR is calculated during “simulated” and not “real” hyper-
emia. To this end, the authors assume that “microcirculation reacts
predictably to maximal hyperemic conditions in patients with
normal coronary flow.” This sentence is substantiated by a bibli-
ographic reference that demonstrates the reproducibility of the
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April 10, 2012:1407–11measurement of coronary flow reserve (CFR) using different agents
but not its interpatient reproducibility (2). In contrast, it is well-
nown that CFR is extremely variable in different patients, being
nfluenced, among the other things, by risk factors and age (3,4).
Second, the value of FFR is influenced not only by stenosis
everity, but also by the amount of viable myocardium subtended by
he epicardial coronary branch harboring the stenosis (5). This implies
hat a stenosis localized on the proximal left anterior descending
oronary artery would have a completely different functional signifi-
ance, and thus a different FFR, compared with an identical lesion on
second obtuse marginal branch. Similarly, the same stenosis would
e associated with a different FFR value in the presence of viable or
carred myocardium (5). Of note, in the paper by Koo et al. (1), 17%
f patients had a history of myocardial infarction.
Third, the incremental diagnostic yield of FFR is related to the
valuation of intermediate coronary stenoses (i.e., those usually
anging from 50% to 70% on visual angiographic assessment). In
he paper by Koo et al. (1), less than one of third of all lesions were
ithin this range on coronary computed tomography angiography
valuation. In the subset of coronary intermediate stenoses, al-
hough the overall accuracy of FFRCT was still acceptable (83%),
the sensitivity and positive predictive value were quite low (66.7%
for both). This challenges the clinical value of FFRCT in the
ssessment of those lesions for which clear proof of functional
ignificance is indeed needed.
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Reply
We thank Dr. De Caterina and colleagues for their interest in our
study, which demonstrates a high diagnostic performance of a
noninvasive method for computing fractional flow reserve (FFR)
from coronary computed tomography angiograms (FFRCT) (1).FRCT is calculated by computational simulation of adenosine-
mediated hyperemia rather than by actual administration of
adenosine. This allows FFRCT to determine coronary flow and
ressure without additional medications or image acquisition.
alculation of FFRCT is enabled by a predictable response of
denosine to reduce microcirculatory resistance downstream of
picardial coronary arteries. As discussed in our paper, the micro-
irculation reacts predictably to maximal hyperemia in patients
ith normal coronary flow, which reflects the fact that the maximal
otential change in peripheral resistance from baseline to hyper-
emic conditions is preserved for microcirculatory vascular beds. In
patients without coronary artery disease, the change in epicardial
resistance is small between rest and hyperemia and allows the
establishment of the limits of maximal change in microcirculatory
resistance achievable in patients with microcirculatory dysfunction.
Notably, this concept underscores the very definition of FFR,
which also assumes that hyperemic microcirculatory resistance
distal to a stenosis is identical to the resistance in the hypothetical
case that the coronary arteries have no stenosis.
We agree with Dr. De Caterina and colleagues that coronary
flow reserve (CFR) demonstrates variability for different patients.
CFR is a different metric from FFR, given its dependence on all
factors that affect blood supply to the microcirculation, including
aortic pressure, epicardial resistance, and microcirculatory resis-
tance. In this regard, CFR may be abnormal even as the response
of the microcirculation to adenosine remains normal.
We agree that FFR is influenced by “the amount of viable
myocardium subtended by the epicardial coronary branch harbor-
ing the stenosis.” This input condition is meticulously factored into
all FFRCT models by setting the resistance of a coronary artery
istal to a stenosis to be inversely (but not linearly) related to the
ize of the distal vessel. As blood vessels adapt proportionally to
ow, a vessel feeding a dysfunctional territory will decrease in
aliber and result in increased resistance in FFRCT models. This
adaptive process is time dependent, and, thus, patients with recent
myocardial infarctions were excluded from our study.
We disagree with the claim of Dr. De Caterina and colleagues
that the utility of FFR is limited to lesions of intermediate stenosis.
Angiographic stenosis is a highly unreliable surrogate for ischemia,
in which a significant proportion of anatomically high-grade
lesions do not cause ischemia. Application of FFRCT to these
lesions may be invaluable for avoiding unnecessary invasive proce-
dures provoked by physiologically irrelevant lesions. Conversely,
even for anatomically mild lesions, a non-negligible rate of
ischemia is consistently noted. Application of FFRCT to these
esions may identify patients whose lesions fall below an anatomic
hreshold of “severe” but who experience ischemic symptoms. In
his regard, FFRCT should be considered an invaluable adjunct to
oronary computed tomography angiography for lesions in all
tenosis categories.
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